Vivos Inc (RDGL)

[dg33]

The game with this stock, as with most tiny biotechs, is whether or not the company will run out of cash prior to being able to market their product(s) and do so in a way that they start generating significant revenues and earnings. Either they will or they won't. All the talk about dilution, shorting and manipulation becomes meaningless if they have a drug/device that the vet/human health care industry wants and they are able to market and sell their products at a profit.